Editorial: Natural products as drivers in drug development for neurodegenerative disorders

Silva, Joana; Alvariño, Rebeca; Goettert, Márcia I.; Caruncho, Hector J.; Alves, Celso

http://hdl.handle.net/10400.8/7583

Utilize este identificador para referenciar este registo.

Nome:	Descrição:	Tamanho:	Formato:
Silva et al_2022_fphar-13-932179.pdf		517.51 KB	Adobe PDF	Ver/Abrir

Contacte-nos

Autores

Descrição

Funding : CA acknowledges the support by the Portuguese Foundation for Science and Technology (FCT) through the strategic projects (UIDB/04292/2020 and UIDP/04292/2020) granted to MARE—Marine and Environmental Sciences Centre, Associate Laboratory ARNET (LA/P/0069/2020), and CROSS-ATLANTIC (PTDC/BIA-OUT/29250/2017), co-financed by European Regional Development Fund (FEDER), through the Operational Programme for Competitiveness and Internationalization (COMPETE 2020). This work was also supported by FCT and CAPES cooperation agreement through project MArTics (FCT/DRI/CAPES 2019.00277. CBM).

Palavras-chave

Natural products (NP), Neuroinflammation Oxidative stress Apoptosis Mechanisms of action Neuropharmacology Drug discovery Ethnopharmacology

URI

http://hdl.handle.net/10400.8/7583

Citação

Silva J, Alvariño R, Goettert MI, Caruncho HJ and Alves C (2022), Editorial: Natural products as drivers in drug development for neurodegenerative disorders. Front. Pharmacol. 13:932179. doi: 10.3389/fphar.2022.932179